Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis

NCT00318994 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00318994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00318994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2002
Completion date
May 31, 2007
Enrollment
6
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis